Emergency medicine Australasia : EMA
-
Wong briefly summarises COVID pharmaceutical therapies that are currently in trial, and importantly have received media attention.
Highlighting that off-label use of these drugs may be important causes of future toxicological presentations to emergency departments, especially for those widely used in the community for other indications (eg. Plaquenil, Kaletra, colchicine...).
Briefly discussed are:
- Chloroquine/hydroxychloroquine
- Azithromycin
- Kaletra (Lopinavir/ritonavir)
- Colchicine
- Ivermectin
- Tocilizumab
- Thaildomide
- Remdesivir
-
Emerg Med Australas · Aug 2020
Shetty test in ankle and foot trauma: An emergency department pilot study assessing specificity and sensitivity.
To assess the potential impact of the Shetty test over Ottawa ankle foot rules (OAFR) on plain imaging utilisation in the ED. ⋯ Shetty test may safely reduce unneeded radiographs in ED. Further research is warranted.
-
Emerg Med Australas · Aug 2020
Incidence and outcomes of aortic dissection for emergency departments in New South Wales, Australia 2017-2018: A data linkage study.
The aims of the present study were to describe the age-specific incidence and 30-day mortality of aortic dissection patients presenting to the EDs in New South Wales (NSW). ⋯ The present study found the incidence of aortic dissection within the NSW population to be 3.4 per 100 000. The incidence of aortic dissection in our population increased from 8.6 per 100 000 for people aged between 60 and 80 years to 32 per 100 000 for those aged over 80 years.
-
Emerg Med Australas · Aug 2020
Directors of emergency medicine's beliefs about, barriers to, and enablers of solutions to emergency department crowding and access block.
To identify opportunities for directors of emergency medicine (DEMs) to lead change efforts to address ED crowding and access block. ⋯ Addressing the political and cultural forces that sustain ED crowding and access block are key adaptive challenges requiring DEM leadership.